Litigation Details for Vifor Pharma, Inc. v. Alkem Laboratories Ltd. (D. Del. 2020)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2020-01-23
Court	District Court, D. Delaware	Date Terminated	2022-06-02
Cause	35:271 Patent Infringement	Assigned To	Maryellen Noreika
Jury Demand	Defendant	Referred To
Parties	VIFOR (INTERNATIONAL) LTD.
Patents	8,147,873; 8,337,824; 9,492,476; 9,925,212
Attorneys	Mary Catherine Roper
Firms	Heyman Enerio Gattuso & Hirzel LLP
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-11-23	129	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,147,873; 8,337,824; 9,492,476… 2020 2 June 2022 1:20-cv-00106 835 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
2020-01-22	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,147,873 B2 ;US 8,337,824 … 2020 2 June 2022 1:20-cv-00106 835 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
2021-07-20	90	Order - -Memorandum and Order	terms of U.S. Patent Nos. 8,147,873 (“the ’873 Patent”), 8,337,824 (“the ’824 Patent”), 9,492,476 (“…four patents, but only one term in one of those patents, U.S. Patent No. 8,147,873, is …(“the ’476 Patent”) and 9,925,212 (“the ’212 Patent”) with agreed-upon constructions are construed as… exchange cations” (’476 Patent, claim 1; ’212 Patent, claim 1) Further, as announced… the entire patent.” Id. at 1321 (internal quotation marks omitted). The patent specification	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document